Leadership Team

 

David Green - serves as our Chief Executive Officer. Mr. Green has been the President and a member of the board of directors of Harvard Bioscience since March 1996 and will remain a director. Mr. Green’s previous experiences include working as a strategy consultant with Monitor Company, a strategy consulting company, in Cambridge, Massachusetts and Johannesburg, South Africa from June 1991 until September 1995 and a brand manager for household products with Unilever PLC, a packaged consumer goods company, in London from September 1985 to February 1989. Mr. Green currently sits on the Advisory Board of the Harvard Business School Healthcare Initiative and on the Executive Advisory Board of The University of Massachusetts Lowell Nanomanufacturing Center. Mr. Green graduated from Oxford University with a B.A. Honors degree in physics and holds a M.B.A. degree with distinction from Harvard Business School.

 

Tom McNaughton - serves as our Chief Financial Officer. Mr. McNaughton was the Chief Financial Officer of Harvard Bioscience since November 2008. From 2007 to 2008, Mr. McNaughton was a consultant providing services primarily to an angel-investing group and a silicon manufacturing start-up. From 2005 to 2007, Mr. McNaughton served as Vice President of Finance and Chief Financial Officer for Tivoli Audio, LLC, a venture capital-backed global manufacturer of premium audio systems. Prior to joining Tivoli Audio, LLC, from 1990 to 2005, Mr. McNaughton served in various managerial positions in the areas of financial reporting, treasury, investor relations, and acquisitions within Cabot Corporation, a global manufacturer of fine particulate products, and served from 2002 to 2005 as Finance Director, Chief Financial Officer of Cabot Supermetals, a $350 million Cabot division that provides high purity tantalum and niobium products to the electronics and semiconductor industries. Mr. McNaughton practiced from 1982 to 1990 as a Certified Public Accountant in the audit services group of Deloitte & Touche, LLP. Mr. McNaughton holds a B.S. in accounting and finance from Babson College. .

 

Saverio LaFrancesca – Chief Medical Officer... Is a cardiothoracic surgeon with extensive clinical experience committed to the clinical translation of transformative medical research. Saverio has a unique combination of experience that features over 25 years of academic clinical surgical practice and innovative research, with a foundation in the cardiovascular, thoracic transplantation, cardiac assist device and regenerative medicine fields. He joins the company from the Dept. of Cardiovascular Surgery and Transplantation at the DeBakey Heart and Vascular Center at the Houston Methodist Hospital, where he developed the current surgical and perfusion techniques for thoracic organ procurement and preservation and where he was also the Director of the Exvivo lung perfusion laboratory. Previously he was an attending surgeon at the Department of Cardiopulmonary Transplantation at the Texas Heart Institute in Houston, Texas. Saverio still holds an appointment as Associate Professor of Surgery at the University of Rome "La Sapienza” in Rome, Italy. He received his M.D. in medicine and surgery in 1985 at the University of Palermo. Saverio did his Residency in Cardiovascular Surgery in the Dept. of Cardiovascular Surgery at the University of Rome "La Sapienza". He then completed his post-doctoral training with fellowships at the Texas Heart Institute under the supervision of pioneer surgeon Denton Cooley. He was also a Clinical/ Research fellow at McGill University in Montréal, Québec, Canada and at the Baylor College of Medicine in Houston. Saverio holds UNOS certifications as heart transplant surgeon and lung transplant surgeon. He is also certified as surgeon for the use of the HeartMate and the Jarvik 2000 left ventricular assist devices.

 

Ron Sostek – Vice President of Business Development …… For over 40 years, Ron has combined his deep technical knowledge with commercial experience to identify key market needs and successfully develop and commercialize products for the scientific computing and instrumentation marketplace. Over the last 15 years, as Vice President of Business Development, he has been key in identifying and integrating companies and product lines that expanded the ability of Harvard Apparatus to meet it’s partners current requirements and future needs. As Strategic Business Manager at the IBM Scientific and Technology Group he identified and initiated programs for electronic submission of clinical trials to FDA. As Vice President of Marketing at Mettler-Toledo Ingold process analytics, he led an effort to characterize & develop an in-line sterilized probe cleaning station. As Vice President of Marketing at Bio-Rad/ Digilab he identified the need for and commercialized a MID IR imaging spectroscopy microscope. During his role of President of North American Operations of Shimadzu/ Kratos he was a key element in developing products for computerized control/acquisition/analysis of TOF/TOF SIMS MS/AUGER, & ESCA spectral and imaging instrumentation. Ron identified several market segments that allowed him as a Marketing Manager of Waters to characterize and develop instrumentation for in-line sample clean-up (multi-dimensional) / microbore, glucose and amino acid analysis systems utilizing HPLC Systems.

 

Al Correia – Vice President of Sales & Manufacturing……Previously as Vice President of Operations at Cambridge Biomedical, he was involved in all aspects of the company including Sales, Marketing, development and the laboratory where he designed and built the new laboratory facility. As Vice President of Marketing at VelQuest Corp, a provider of GMP compliance software to the pharmaceutical industry. He has presented over 50 workshops and seminars at international conferences and meetings on various compliance topics including electronic record requirements, data acquisition and Part 11. As Vice President and General Manager at Unisyn Technologies, a contract manufacturer of Pre-clinical, Phase 1 and Phase 2 therapeutics, he designed built and ran a GMP production plant. A major project completed while head of development was to design a new line of bioreactors. Prior to Unisyn, Al held several technical and marketing management positions at Zymark Corporation and was a cofounder of Xydex, a sample handling company that was acquired by Genex. He also held positions in the sales and application laboratory at Waters Associates. Al received a degree in Chemistry from the College of the Holy Cross.

 

David Olsen – Director of Quality Assurance and Regulatory Affairs . David brings 25 years years of experience as a Quality and Regulatory Affairs professional in Medical Devices, Diagnostics and Biotechnology. He has a solid working knowledge of the Medical Device Regulations and Standards with a demonstrated ability to build compliant Quality Systems that incorporate industry best practices and also meet business objectives; He has had extensive experience in product development and licensure within the U.S., Canada, European Union, Brazil, India and China. Previously from Seracare where as Vice President, Corporate Quality and Regulatory Affairs he was responsible for the management of all Quality and Regulatory activities for $60MM IVD Biotechnology Company specializing in bulk plasma manufacturing and the manufacture of serological and nucleic acid reference materials.

 

Candace Brayfield – Director of Cell Biology. Candace joined the company from the genzyme corporation where she was a senior scientist where she supported manufacturing operations and product development activities. In her prior role as a Process / Analytical Scientist she led a diverse range of projects from analytical assay development and validation for product characterization to 2nd generation product development. She was also involved in regulatory filings such as MAA and BLA submissions. She brings a wealth of experience in areas such as neuronal, bone marrow and adipose-derived stem cells; cell-biomaterial interactions; cell therapy; 3D bioreactor systems and cell-based bioassays. Candace received her B.S. from the University of Rochester in Biomedical Engineering and her Ph.D. from the University of Pittsburgh. She also performed post-doctoral studies at the McGowan Institute for Regenerative Medicine in Pittsburgh, PA.